Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients aged 18 to 75 years, regardless of gender; 2. Patients who have undergone colorectal cancer surgery, are pathologically diagnosed as colorectal cancer, and plan to receive chemotherapy; 3. Patients with expected survival time >= 6 months; 4. Patients who can comply with themselves or their family members, are willing and able to use digital platforms for self-management, and are willing to communicate with project team staff on WeChat or by phone; 5. Sign the informed consent form voluntarily, and complete the questionnaire survey and follow-up visits as required; when unable to sign the informed consent form and complete the questionnaire survey and follow-up visits by themselves, legal representatives or guardians can act on their behalf.
Exclusion criteria
Exclusion criteria: 1. Patients with advanced malignant tumors of other systems or organs; 2. Patients who cannot tolerate chemotherapy due to physical conditions, or refuse chemotherapy; 3. Patients with any of the following conditions: (1) Renal dysfunction (BUN, Cr > 1.5 ULN or eGFR 2.5 ULN); (5) Severe cardiopulmonary dysfunction; (6) Neuropsychiatric diseases; (7) There are blood diseases, HIV and other conditions that are clinically considered inappropriate to participate in this study; 4. There are metal objects in the body (such as: internal fixation, pacemaker or stent, etc.) patients who cannot accept relevant tests or affect the test data; 5. Patients who are unable to take care of themselves and be active in life and eating (ADL score < 60 points); 6. After evaluation by nutritionists and doctors, patients who have eating contraindications (such as gastrointestinal bleeding, intestinal paralysis/obstruction, intestinal fistula, severe diarrhea, etc.), who cannot eat semi-liquid or receive enteral nutrition therapy; 7. Patients with contraindications to exercise intervention after evaluation by rehabilitation therapists; 8. Participating in other clinical researchers or other conditions that the researchers think are not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass and strength;Nutrition assessment;physical examination; | — |
Countries
China
Contacts
Ningbo Huamei Hospital, University of Chinese Academy of Sciences (Ningbo Second Hospital)